GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma

Conditions:   Refractory Neuroblastoma;   Relapsed Neuroblastoma;   High-risk Neuroblastoma Intervention:   Biological: GPC2 CAR T cells Sponsors:   Stephan Grupp MD PhD;   Children's Hospital of Philadelphia;   Tmunity Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials